Jump to content

mdn2

Members
  • Content Count

    8,669
  • Joined

  • Last visited

Profile Information

  • Gender
    Male

Recent Profile Visitors

11,986 profile views
  1. mdn2

    Shazam! - Non-grimdark DC movie

    I'm seeing this on Wednesday. Really looking forward to it now..
  2. mdn2

    X-Men - Dark Phoenix

    They're going to have to. There's no way they can merge this XMen universe with the MCU. I can see this being the last seperate XMen film before a total reboot.
  3. I've been avoiding this thread for the last couple of weeks, but I've had the day booked off for this (first time I've ever done that for a game). I've only done the first hour or so, but it feels so different to a Souls game, yet familiar at the same time. Considering parrying was never exactly my strong point, I have a feeling I'm gonna have to learn it pretty quickly here...
  4. mdn2

    Nintendo eShop (Software Chatter)

    I loved Night In The Woods. It really does a great job getting across how it feels to be part of a small, dying town somewhere in the US and has some of the best characterisation I've ever seen in a game. The ending is proper crazy as well.
  5. mdn2

    Xbox One backwards compatibility

    In the last few weeks we've had the Lost Planet Trilogy, Ace Combat 6, Crackdown 2 (your mileage may vary in that one) and Resident Evil: Code Veronica X. That's not bad.
  6. mdn2

    Microsoft Rewards

    Yeah, I paid for Sekiro completely with the vouchers. It works out well for 5 minutes work every day.
  7. mdn2

    Nuclear Throne

    This is out now on Switch: £10.99.
  8. Apparently the DLC will be day and date with the Xbox and PC versions as well.
  9. mdn2

    My Friend Pedro (2019)

    New trailer!
  10. Its not on the store yet. I've just checked.
×

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. Use of this website is subject to our Privacy Policy, Terms of Use, and Guidelines.